Article info

Original research
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer

Authors

  • Markus Hecht Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, GermanyComprehensive Cancer Center Erlangen-EMN, Erlangen, GermanyDeutsches Zentrum Immuntherapie, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Markus Eckstein Comprehensive Cancer Center Erlangen-EMN, Erlangen, GermanyInstitute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Sandra Rutzner Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, GermanyComprehensive Cancer Center Erlangen-EMN, Erlangen, GermanyDeutsches Zentrum Immuntherapie, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Jens von der Grün Department of Radiation Oncology, University Hospital Frankfurt, Goethe-Universitat Frankfurt am Main, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Thomas Illmer Private Praxis Oncology, Arnoldstraße, Dresden, Germany PubMed articlesGoogle scholar articles
  • Gunther Klautke Department of Radiation Oncology, Chemnitz Hospital, Chemnitz, Germany PubMed articlesGoogle scholar articles
  • Simon Laban Department of Otolaryngology - Head & Neck Surgery, Universität Ulm, Ulm, Germany PubMed articlesGoogle scholar articles
  • Matthias G Hautmann Department of Radiotherapy, University Hospital Regensburg, Universität Regensburg, Regensburg, Germany PubMed articlesGoogle scholar articles
  • Thomas B Brunner Department of Radiation Oncology, University Hospital Magdeburg, Otto von Guericke Universität Magdeburg, Magdeburg, Germany PubMed articlesGoogle scholar articles
  • Bálint Tamaskovics Department of Radiation Oncology, University Hospital Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Dusseldorf, Germany PubMed articlesGoogle scholar articles
  • Axel Hinke Clinical Cancer Research Consulting (CCRC), Düsseldorf, Germany PubMed articlesGoogle scholar articles
  • Jian-Guo Zhou Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, GermanyComprehensive Cancer Center Erlangen-EMN, Erlangen, GermanyDeutsches Zentrum Immuntherapie, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Benjamin Frey Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, GermanyComprehensive Cancer Center Erlangen-EMN, Erlangen, GermanyDeutsches Zentrum Immuntherapie, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Anna-Jasmina Donaubauer Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, GermanyComprehensive Cancer Center Erlangen-EMN, Erlangen, GermanyDeutsches Zentrum Immuntherapie, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Ina Becker Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, GermanyComprehensive Cancer Center Erlangen-EMN, Erlangen, GermanyDeutsches Zentrum Immuntherapie, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Sabine Semrau Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, GermanyComprehensive Cancer Center Erlangen-EMN, Erlangen, GermanyDeutsches Zentrum Immuntherapie, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Arndt Hartmann Comprehensive Cancer Center Erlangen-EMN, Erlangen, GermanyInstitute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Panagiotis Balermpas Department of Radiation Oncology, University Hospital Frankfurt, Goethe-Universitat Frankfurt am Main, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Wilfried Budach Department of Radiation Oncology, University Hospital Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Dusseldorf, Germany PubMed articlesGoogle scholar articles
  • Udo S Gaipl Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, GermanyComprehensive Cancer Center Erlangen-EMN, Erlangen, GermanyDeutsches Zentrum Immuntherapie, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Heinrich Iro Comprehensive Cancer Center Erlangen-EMN, Erlangen, GermanyDeutsches Zentrum Immuntherapie, Erlangen, GermanyDepartment of Otolaryngology - Head & Neck Surgery, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Antoniu-Oreste Gostian Comprehensive Cancer Center Erlangen-EMN, Erlangen, GermanyDeutsches Zentrum Immuntherapie, Erlangen, GermanyDepartment of Otolaryngology - Head & Neck Surgery, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Rainer Fietkau Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, GermanyComprehensive Cancer Center Erlangen-EMN, Erlangen, GermanyDeutsches Zentrum Immuntherapie, Erlangen, Germany PubMed articlesGoogle scholar articles

Citation

Hecht M, Eckstein M, Rutzner S, et al
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.